Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 38 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

32%

12 trials in Phase 3/4

Results Transparency

0%

0 of 21 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
9(29.0%)
N/A
8(25.8%)
Phase 1
6(19.4%)
Phase 2
5(16.1%)
Phase 4
3(9.7%)
31Total
Phase 3(9)
N/A(8)
Phase 1(6)
Phase 2(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials
NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT06014801Phase 2Recruiting

Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

Role: collaborator

NCT03506113Phase 4Completed

GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial

Role: collaborator

NCT03591328Unknown

Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II (EMERALD II) Study

Role: collaborator

NCT04600063Not ApplicableUnknown

Isolation Procedure vs. Conventional Procedure During Distal Pancreatectosplenectomy for Pancreatic Cancer

Role: lead

NCT04444037Completed

Impact of OCT Imaging on Decision Making During PCI in ACS Patients

Role: collaborator

NCT02777463Completed

The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.

Role: lead

NCT03253068Phase 2Unknown

Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer

Role: lead

NCT03863652Completed

Optimal Hemostasis Duration for Percutaneous Coronary Intervention Via Snuffbox Approach

Role: collaborator

NCT01261234Not ApplicableCompleted

Carotid Artery Stenting With Cilostazol Addition for Restenosis

Role: collaborator

NCT02148549Phase 1Completed

Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study

Role: lead

NCT01898780Phase 3Unknown

Horizontal Mattress vs. Interrupted Suture in Surgical Techniques of Pancreaticojejunostomy

Role: lead

NCT02926183Phase 2Unknown

Study of NAC of GA Therapy for Patients With BRPC

Role: lead

NCT01065688Phase 3Completed

A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer

Role: lead

NCT03317886Phase 3Unknown

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Role: lead

NCT01621438Unknown

Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)

Role: collaborator

NCT02374775Unknown

Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamic

Role: collaborator

NCT01760967Phase 4Completed

Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial

Role: lead

NCT02871804Phase 3Unknown

Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy

Role: lead

NCT01384617Not ApplicableCompleted

Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy

Role: lead